GEN Exclusives

More »

GEN News Highlights

More »
Aug 29, 2007

FDA Approves Roche’s West Nile Virus Blood Screening Test

  • The FDA approved Roche’s BLA related to its test for direct detection of West Nile virus in donated human blood and plasma. West Nile can be transmitted by transfusion of infected blood or blood products.

    The test, called the cobas TaqScreen West Nile Virus Test, enables detection of the virus earlier in the infection cycle in donors who may show no symptoms of disease, according to the company.

    The test is designed to run on the cobas 201 system, Roche’s flexible, modular instrument platform that automates each step of the real-time PCR blood screening process. The test uses Roche’s PCR technology to detect the genetic material of the West Nile virus directly in blood.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »